F/m Emerald Life Sciences Innovation ETF Rating $25.08 -0.56 (-2.16%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$25.08 -0.01 (-0.02%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsTrendsBuy This Stock F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.98Holdings in LFSC have an aggregate rating of Moderate Buy based on 269 analyst ratings issued in the past year covering 25 companies (92.8% of the portfolio).LFSC Aggregate Price Target$25.09High Prediction$25.09Average Prediction$25.09Low Prediction$25.09Holdings in LFSC have an aggregate price target of $25.09 and a range of $25.09 to $25.09 covering 25 companies (92.8% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 LFSC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.25%BBIOBridgeBio Pharma$46.47+0.4%4.6697 of 5 stars3.00$60.21 29.6%14Analyst Upgrade6.22%LIVNLivaNova$44.33-5.0%3.1062 of 5 stars3.00$59.29 33.7%8News CoveragePositive News6.02%TMDXTransMedics Group$112.46-9.9%2.2587 of 5 stars2.80$127.33 13.2%10News CoveragePositive NewsAnalyst Revision6.02%SLNOSoleno Therapeutics$81.57+1.6%4.6202 of 5 stars3.09$108.70 33.3%11Trending NewsAnalyst ForecastHigh Trading Volume5.79%RDNTRadNet$55.48-3.5%4.1649 of 5 stars3.50$69.60 25.5%6News CoveragePositive NewsAnalyst Forecast5.13%TVTXTravere Therapeutics$16.47-0.5%3.8307 of 5 stars2.87$32.14 95.2%154.87%KALVKalVista Pharmaceuticals$14.52-6.4%4.092 of 5 stars3.11$26.29 81.0%9Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionGap DownHigh Trading Volume4.77%MMSIMerit Medical Systems$93.49-1.8%4.3155 of 5 stars2.89$109.11 16.7%9Positive NewsAnalyst Forecast4.44%COLLCollegium Pharmaceutical$32.52-1.5%4.0321 of 5 stars2.75$43.75 34.5%4Positive NewsBuyback Announcement4.16%RAREUltragenyx Pharmaceutical$29.51-4.9%3.9446 of 5 stars2.93$85.36 189.2%14Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume4.04%INSMInsmed$98.18+1.6%4.5407 of 5 stars3.00$108.07 10.1%17Positive NewsAnalyst ForecastInsider Trade3.87%ETNB89BIO$11.00+2.0%2.11 of 5 stars3.00$26.43 140.3%8News Coverage3.60%ATECAlphatec$10.99-5.1%4.3509 of 5 stars2.89$17.89 62.8%9Positive News3.55%GHGuardant Health$50.25-2.0%4.1139 of 5 stars3.00$53.76 7.0%213.11%MDGLMadrigal Pharmaceuticals$315.46+0.3%4.2557 of 5 stars2.89$420.63 33.3%9News CoveragePositive News3.02%WVEWAVE Life Sciences$7.70-3.1%4.6026 of 5 stars2.92$20.50 166.2%122.67%CORTCorcept Therapeutics$71.88-0.2%4.8124 of 5 stars3.00$138.25 92.3%52.56%MIRMMirum Pharmaceuticals$52.66-0.7%2.8511 of 5 stars3.13$65.50 24.4%8News CoverageAnalyst Forecast2.27%ITGRInteger$119.73-1.7%2.882 of 5 stars3.00$145.00 21.1%9News Coverage2.10%COGTCogent Biosciences$10.98+1.2%3.0249 of 5 stars2.82$18.00 63.9%11Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume2.07%AXSMAxsome Therapeutics$108.98-1.6%4.7595 of 5 stars3.06$172.33 58.1%16Analyst Revision1.82%ACADACADIA Pharmaceuticals$20.98-4.9%4.6461 of 5 stars2.71$27.88 32.9%17Analyst Revision1.62%AKROAkero Therapeutics$51.57-0.8%3.3988 of 5 stars3.00$82.50 60.0%6Insider Trade1.47%SYRESpyre Therapeutics$15.69-1.7%2.2539 of 5 stars3.25$53.40 240.3%8Positive News1.38%GMEDGlobus Medical$57.09-1.2%4.9872 of 5 stars2.62$94.00 64.7%13Positive News This page (NASDAQ:LFSC) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.